Litigation

Recent Posts

West Virginia High Court Vacates $4.47M Judgment; FDA Warning Letters Not Matter Of Law
Posted on 19 Nov 2010 by Tom Moylan

CHARLESTON, W.Va. -- (Mealey's) The West Virginia Supreme Court of Appeals on Nov. 18 reversed a $4,475,000 consumer law judgment against Johnson & Johnson concerning the marketing of Risperdal and Duragesic after agreeing with the defendant that... Read More

Tags: Risperdal , State of West Virginia v. Johnson & Johnson , Food and Drug Administration , personal injury , Judgment , product liability , Darrell V. McGraw Jr. , fentanyl , DHCP , FDA , Consumer Credit and Protection Act , Litigation , skin patch , lawsuit , torts , Janssen Pharmaceutical Products , diabetes , Duragesic , Dear Health Care Professional , Johnson & Johnson , hyperglycemia , antipsychotic drug , West Virginia Supreme Court of Appeals